Systemic GM-CSF recruits effector T cells into the tumor microenvironment in localized prostate cancer

Granulocytic-macrophage colony-stimulating factor (GM-CSF) is used as an adjuvant in cancer vaccine trials and has the potential to enhance antitumor efficacy with immunotherapy; however, its immunologic effects are not fully understood. Here, we report results from a phase 1 study of neoadjuvant GM...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Immunol Res
Prif Awduron: Wei, Xiao X., Chan, Stephen, Kwek, Serena, Lewis, Jera, Dao, Vinh, Zhang, Li, Cooperberg, Matthew R., Ryan, Charles J., Lin, Amy M., Friedlander, Terence W., Rini, Brian, Kane, Christopher, Simko, Jeffry P., Carroll, Peter R., Small, Eric J., Fong, Lawrence
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115633/
https://ncbi.nlm.nih.gov/pubmed/27688020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0042
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg